JP2007523952A5 - - Google Patents

Download PDF

Info

Publication number
JP2007523952A5
JP2007523952A5 JP2007500908A JP2007500908A JP2007523952A5 JP 2007523952 A5 JP2007523952 A5 JP 2007523952A5 JP 2007500908 A JP2007500908 A JP 2007500908A JP 2007500908 A JP2007500908 A JP 2007500908A JP 2007523952 A5 JP2007523952 A5 JP 2007523952A5
Authority
JP
Japan
Prior art keywords
disease
hydroxy
syndrome
quinolinyl
oxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007500908A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007523952A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/005467 external-priority patent/WO2005082857A1/en
Publication of JP2007523952A publication Critical patent/JP2007523952A/ja
Publication of JP2007523952A5 publication Critical patent/JP2007523952A5/ja
Pending legal-status Critical Current

Links

JP2007500908A 2004-02-25 2005-02-22 選択的エストロゲンレセプターモジュレーターとして使用するための置換キノリン化合物 Pending JP2007523952A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54754404P 2004-02-25 2004-02-25
PCT/US2005/005467 WO2005082857A1 (en) 2004-02-25 2005-02-22 Substituted quinoline compounds for use as selective estrogen receptor modulator

Publications (2)

Publication Number Publication Date
JP2007523952A JP2007523952A (ja) 2007-08-23
JP2007523952A5 true JP2007523952A5 (cg-RX-API-DMAC7.html) 2007-12-06

Family

ID=34910914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007500908A Pending JP2007523952A (ja) 2004-02-25 2005-02-22 選択的エストロゲンレセプターモジュレーターとして使用するための置換キノリン化合物

Country Status (4)

Country Link
US (1) US7405303B2 (cg-RX-API-DMAC7.html)
EP (1) EP1727802A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007523952A (cg-RX-API-DMAC7.html)
WO (1) WO2005082857A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11513390A (ja) * 1995-10-06 1999-11-16 アーチ デベロップメント コーポレイション 細胞殺傷のウイルス増強のための方法および組成物
CA2571309A1 (en) * 2004-06-22 2006-01-05 Smithkline Beecham Corporation Chemical compounds
WO2007099410A2 (en) * 2005-11-09 2007-09-07 Hormos Medical Ltd. Formulations of fispemifene
JP2009525278A (ja) * 2006-01-30 2009-07-09 メルク エンド カムパニー インコーポレーテッド 脂肪酸シンターゼ（ｆａｓ）のインヒビター
BRPI0711525A2 (pt) 2006-06-02 2011-11-01 Pear Tree Women S Health Care composição farmacêutica e método para tratar sintomas de vaginite atrófica
WO2008099060A2 (en) * 2007-02-14 2008-08-21 Hormos Medical Ltd Methods for the preparation of fispemifene from ospemifene
PL2121553T3 (pl) * 2007-02-14 2012-11-30 Hormos Medical Ltd Sposób wytwarzania cennych terapeutycznie pochodnych trifenylobutenu
US8980840B2 (en) * 2009-01-13 2015-03-17 Schepens Eye Research Institute Therapeutic modulation of vaginal epithelium boundary lubrication
US9321712B2 (en) 2012-10-19 2016-04-26 Fermion Oy Process for the preparation of ospemifene
CN105294557B (zh) * 2015-09-30 2017-10-03 沈阳药科大学 7‑羟基‑6‑芳甲酰基喹啉酮类化合物的制备及其应用
EP3658560A4 (en) 2017-07-25 2021-01-06 Crinetics Pharmaceuticals, Inc. SOMATOSTAT IN MODULATORS AND USES THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3101544A1 (de) * 1981-01-20 1982-08-19 Hoechst Ag, 6000 Frankfurt "chinolinoxy-phenoxypropionsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als herbizide"
EP1395563B1 (en) 2001-05-22 2006-03-29 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods

Similar Documents

Publication Publication Date Title
JP2007523952A5 (cg-RX-API-DMAC7.html)
JP2007500705A5 (cg-RX-API-DMAC7.html)
JP2008512458A5 (cg-RX-API-DMAC7.html)
JP2015526487A5 (cg-RX-API-DMAC7.html)
JP2022504706A (ja) 甲状腺ホルモン受容体作動薬
JP2013525433A5 (cg-RX-API-DMAC7.html)
RU2682660C2 (ru) Способ получения ингибитора PDE4
CN1283183A (zh) 具有mmp和tnf抑制活性的异羟肟酸和羧酸衍生物
CA2843436A1 (en) Novel 17.beta.-heteroaryl-substituted steroids as modulators of gaba a receptors
EP1441735A1 (en) N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
CN107021958A (zh) Fxr受体激动剂
JP2010511010A5 (cg-RX-API-DMAC7.html)
CN109053751A (zh) 具有螺环结构的fxr调节剂
JP2013537919A5 (cg-RX-API-DMAC7.html)
CA2533812A1 (en) Substituted cycloalkylidene compounds
JP7647552B2 (ja) Ｅｐ２アンタゴニスト
RU2006145200A (ru) Химические соединения
WO2016073889A1 (en) Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
JP2008503588A5 (cg-RX-API-DMAC7.html)
EP2593102A1 (en) Oxazole derivatives useful as modulators of faah
FI74279B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara trans-3-(4-oxo-4h-kinazolin-3-yl)-2- propensyraderivat.
CN111655678A (zh) 细胞凋亡信号调节激酶-1抑制剂及其应用
EP1581501A1 (en) 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors
CN1732163A (zh) 作为抗炎和免疫调节及抗增殖试剂的芳香化合物
JP2008533012A (ja) ２−（３−フルオロ−４−ヒドロキシフェニル）−７−ビニル−１，３−ベンゾキサゾール−５−オールの結晶形成およびエストロゲンレセプターモジュレーターとしてのその使用